Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Questionnaire Study Concerning Artificial Intelligence

3 februari 2022 bijgewerkt door: Maastricht University Medical Center

Questionnaire Study Concerning Artificial Intelligence and Its Application in (Gastrointestinal) Healthcare - Patients' and Physicians' Perspectives

This study aims to investigate the knowledge, experience, and opinion on AI among gastroenterology (GI) patients, gastroenterologists, and GI-fellows, particularly concerning implementation and application of AI (in assisting clinicians) in healthcare. The secondary aims are to investigate (dis)advantages of AI use in healthcare and the availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.

Studie Overzicht

Toestand

Voltooid

Conditie

Gastro-intestinale aandoeningen

Interventie / Behandeling

Ander: Questionnaire

Gedetailleerde beschrijving

In recent years, important developments have been made in the field of artificial intelligence (AI). These developments have led to the large-scale application of AI in our everyday lives and AI-research within healthcare. A potentially promising application of AI lies in imaging analysis. For example, within gastroenterology this means the detection and classification of colorectal polyps and Barrett's neoplasia, disease severity scoring of inflammatory bowel diseases, and differentiating pancreatic cancer from chronic pancreatitis.

Despite the investments in AI-research, there is a lack in knowledge concerning patients' and physicians' perspectives on AI in healthcare. This prospective questionnaire study investigates these perspectives, obtaining data from both gastroenterology (GI) patients and GI-physicians within the Netherlands. The questionnaires focus on the knowledge, experience, and opinion of AI, particularly concerning the implementation of AI in (gastroenterology) healthcare. Furthermore, the current (endoscopic) infrastructure within Dutch hospitals will be investigated for its readnessy for AI.

Studietype

Observationeel

Inschrijving (Werkelijk)

457

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

Nederland
- Limburg
  - Maastricht, Limburg, Nederland, 6202AZ
    - Maastricht University Medical Center
- Noord-Brabant
  - Eindhoven, Noord-Brabant, Nederland, 5623 EJ
    - Catharina Ziekenhuis Eindhoven

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

18 jaar en ouder (Volwassen, Oudere volwassene)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Bemonsteringsmethode

Niet-waarschijnlijkheidssteekproef

Studie Bevolking

Gastroenterology patients who will have an outpatient appointment for an endoscopic procedure in the context of the national bowel cancer screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases, in one of two Dutch hospitals between April 2020 and September 2020.

Gastroenterologists and gastroenterology fellows working in Dutch hospitals.

Beschrijving

Inclusion Criteria:

Gastrointestinal (GI) patients with an outpatient appointment in the gastroenterology department for an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases (in one of the two participating hospitals);
Gastroenterologists working in Dutch hospitals;
Gastroenterology fellows working in Dutch hospitals;
Minimal age of 18 years old.

Exclusion Criteria:

No appropriate understanding of the Dutch language;
Not willing to sign informed consent;
Objection to participate in medical scientific research, reported in the medical file.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

Aantal groepen / cohorten

Cohorten en interventies

Groep / Cohort	Interventie / Behandeling
Gastroenterology patients Patient receiving an endoscopic procedure because of regular care will be considered eligible for inclusion. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases. Patients will be asked to complete a questionnaire concerning AI. No intervention will be administered.	Ander: Questionnaire Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.
Gastroenterology physicians GI physicians (both gastroenterologists and gastroenterology fellows), participating in a yearly gastroenterology and hepatology training day, will be asked for their participation in this study. Physician will be asked to complete a questionnaire concerning AI. No intervention will be administered.	Ander: Questionnaire Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.

Groep / Cohort

Interventie / Behandeling

Gastroenterology patients

Patient receiving an endoscopic procedure because of regular care will be considered eligible for inclusion. Patients receive an endoscopic procedure in the context of the Dutch national screening program, because of gastrointestinal symptoms, or because of follow-up of previously diagnosed bowel diseases.

Patients will be asked to complete a questionnaire concerning AI. No intervention will be administered.

Ander: Questionnaire

Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.

Gastroenterology physicians

GI physicians (both gastroenterologists and gastroenterology fellows), participating in a yearly gastroenterology and hepatology training day, will be asked for their participation in this study.

Physician will be asked to complete a questionnaire concerning AI. No intervention will be administered.

Ander: Questionnaire

Questionnaire concerning artificial intelligence and its implementation in healthcare. GI patients and GI physicians will be provided with slightly different questionnaires.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat	Maatregel Beschrijving	Tijdsspanne
The knowledge on AI investigated by means of a questionnaire Tijdsspanne: 6 months	The knowledge on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.	6 months
The experience with AI investigated by means of a questionnaire Tijdsspanne: 6 months	The experience with AI (in healthcare) among gastroenterology patients and physicians, investigated by means of a questionnaire.	6 months
The opinion on AI investigated by means of a questionnaire Tijdsspanne: 6 months	The oninion on AI in healthcare among gastroenterology patients and physicians, investigated by means of a questionnaire.	6 months

Secundaire uitkomstmaten

Uitkomstmaat	Maatregel Beschrijving	Tijdsspanne
Willingness of physicians to use AI in (gastroenterology) healthcare Tijdsspanne: 6 months	The willingness to apply AI in (gastroenterology) healthcare among gastroenterology physicians.	6 months
Willingness to apply AI in (gastroenterology) healthcare Tijdsspanne: 6 months	The willingness of gastroenterology patients for their physicians to apply AI in (gastroenterology) healthcare.	6 months
Advantages and disadvantages of AI use in (gastroenterology) healthcare Tijdsspanne: 6 months	Important advantages and disadvantages of AI use in (gastroenterology) healthcare among gastroenterology patients and physicians.	6 months
Potential domains within gastroenterology and hepatology for AI use Tijdsspanne: 6 months	Potential domains within gastroenterology and hepatology for AI use indicated by GI physicians.	6 months
Mandatory infrastructure for AI use in healthcare Tijdsspanne: 6 months	The availability of technical facilities and infrastructures within endoscopy to implement and apply AI in Dutch hospitals.	6 months

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Maastricht University Medical Center

Medewerkers

Catharina Ziekenhuis Eindhoven

Onderzoekers

Hoofdonderzoeker: Ad Masclee, Prof Dr MD, Maastricht Universitair Medisch Centrum

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Algemene publicaties

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

8 april 2020

Primaire voltooiing (Werkelijk)

12 augustus 2021

Studie voltooiing (Werkelijk)

12 augustus 2021

Studieregistratiedata

Eerst ingediend

13 januari 2022

Eerst ingediend dat voldeed aan de QC-criteria

26 januari 2022

Eerst geplaatst (Werkelijk)

31 januari 2022

Updates van studierecords

Laatste update geplaatst (Werkelijk)

18 februari 2022

Laatste update ingediend die voldeed aan QC-criteria

3 februari 2022

Laatst geverifieerd

1 februari 2022

Meer informatie

Termen gerelateerd aan deze studie

Trefwoorden

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

METC 2020-2281

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

Beschrijving IPD-plan

Data collected for the study, including individual participant data, will be made available upon request. This data includes deidentified participant data. Additional documents that will be made available are the study protocol, the statistical analysis plan, the questionnaires, and the informed consent forms. Data will be available following publication with no end date. Requests should be methodologically sound proposals with the purpose to achieve aims in the approved proposal. Researchers who request the data should direct the proposal to q.vanderzander@maastrichtuniversity.nl to gain access. Data requestors will need to sign a data access agreement after approval of a proposal.

IPD-tijdsbestek voor delen

Data will be available following publication with no end date.

IPD-toegangscriteria voor delen

Requests should be methodologically sound proposals with the purpose to achieve aims in the approved proposal. Data requestors will need to sign a data access agreement after approval of a proposal.

IPD delen Ondersteunend informatietype

LEERPROTOCOOL
SAP
ICF

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Questionnaire Study Concerning Artificial Intelligence